Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Alirocumab for Alcohol Use Disorder
Recruiting0 awardsPhase 1
Bethesda, Maryland
This trial is testing the effects of alirocumab in people who drink alcohol. People who drink 20 or more drinks per week may be eligible. The trial will last 8 weeks.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service